EQUITY BY DESIGN IN CLINICAL RESEARCH: CANCER TRIALS is a virtual training course communicating an understanding of, and training on best practices for, diversity, equity, and inclusion (DEI) of underrepresented populations in clinical trials. The course is intended to aid cancer centers in improving their ability to enroll underrepresented participants in clinical research and to develop mechanisms for ongoing sustainability of DEI in clinical research. Ethical and regulatory considerations will be included, and practical guidance for commitment, communication, partnership, and conduct will be emphasized. CME credit available.
MODULE 6: ACCOUNTABILITY, ADVOCACY, AND JUSTICE
Accountability, Advocacy and Justice describes processes for incorporating monitoring, review, accountability, and transparency, and considers opportunities for action both to uphold commitments and to advance equity by design in cancer clinical research.
Hosted by The Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, The Center for Cancer Equity and Engagement at Dana-Farber/Harvard Cancer Center, and Mass General Brigham.
The practice of returning IRR is consistently identified by participants as something that participants not only desire but also expect. Returning IRR demonstrates participant-centricity and respect.
A taskforce was convened during 2021 to update and further develop the MRCT Center’s guidance on Returning Individual Research Results to Participants – these resources and tools are ready to be shared, on a new, easy-to-navigate, dedicated website.
This one-hour webinar will include a review of IRR and its importance, a patient advocate describing her own lived experience with IRR, and a live demonstration of the new tools and website.
The fourth conference in the series, “Facilitating Pediatric Medicines Development: Models of Global Cooperation,” focuses on global regulatory cooperation with an eye to building on existing models to strengthen the global regulatory ecosystem for pediatric drug approval.
This two-part webinar will take place on 29 November 2022 at 9-11:30am ET and 30 November 2022 at 9-11am ET. We encourage you to attend both parts of this virtual meeting as part two builds on part one.
The MRCT Center is pleased to announce the third of the 5 part virtual conference series to advance global pediatric clinical trials. Entitled “Assent and consent in the field: culture, context, and respect,” the conference will focus on the cultural context of assent and the challenges and solutions encountered on the ground. The 2-hour agenda will feature a moderated panel of experts who will share their experiences with assent around the world, including how to manage the tension between an (ideal) ethical framework and cultural context.
The webinar will be hosted twice: Tuesday 28 June 2022 at 9-11 am EDT and Wednesday 29 June 2022 at 8-10 pm EDT with similar content but different speakers and panelists, to allow for wide attendance and global participation.
REGISTER for Session 1:Tuesday 28 June 2022 at 9-11 am EDT
REGISTER for Session 2: Wednesday 29 June 2022 at 8-10 pm EDT
The MRCT Center is pleased to announce the third of the 5 part virtual conference series to advance global pediatric clinical trials. Entitled “Assent and consent in the field: culture, context, and respect,” the conference will focus on the cultural context of assent and the challenges and solutions encountered on the ground. The 2-hour agenda will feature a moderated panel of experts who will share their experiences with assent around the world, including how to manage the tension between an (ideal) ethical framework and cultural context.
The webinar will be hosted twice: Tuesday 28 June 2022 at 9-11 am EDT and Wednesday 29 June 2022 at 8-10 pm EDT with similar content but different speakers and panelists, to allow for wide attendance and global participation.
REGISTER for Session 1:Tuesday 28 June 2022 at 9-11 am EDT
REGISTER for Session 2: Wednesday 29 June 2022 at 8-10 pm EDT
The IRB can play an important role in championing the creation of research materials for participants that are clear and understandable. Please join us as we launch a new online Health Literacy training for IRB members and staff. The webinar launch will review health literacy concepts and introduce the online training which is designed to be a self-paced opportunity to learn and apply health literacy principles to the IRB role. The training also offers a facilitation guide to support continued conversations with colleagues about how to implement lessons learned.
Does the IRB play a role in addressing the problem of diversity, inclusion, and equity in clinical research? It is true that the need for change must be systemic and embraced at all levels of the clinical research enterprise, and while IRBs are not the primary driver for assuring diversity, inclusion, and equity in clinical research, IRBs can and should serve as a checkpoint for reviewing research for the principles of DEI. This webinar introduced tools and resources created for IRBs and HRPPs to help drive the change.
Dr. Barbara E. Bierer moderated this webinar, in which MRCT Center Program Manager Dr. Willyanne DeCormier Plosky introduced the background and structure of EbD Metrics Framework and panelists Yasmeen Long (Faster Cures, Milken Institute) and Dr. Rodrigo Garcia (PPD, Thermo Fisher Scientific) discussed their experiences in testing and utilizing it.
The EbD Metrics Framework is a tool developed by the MRCT Center in collaboration with colleagues from professional, trade, academic, regulatory, and patient advocacy organizations. It is designed to advance organizational diversity, equity, and inclusion (DEI) efforts; orient users toward potential entry and follow-up strategies; and provide guidepost measures for assessing and reporting on progress. To access the tool, please visit the EbD Metrics Framework page.
The fourth conference in the series, “Facilitating Pediatric Medicines Development: Models of Global Cooperation,” focuses on global regulatory cooperation with an eye to building on existing models to strengthen the global regulatory ecosystem for pediatric drug approval.
This two-part webinar will take place on 29 November 2022 at 9-11:30am ET and 30 November 2022 at 9-11am ET. We encourage you to attend both parts of this virtual meeting as part two builds on part one.
